Cryopyrin-associated periodic syndrome (CAPS) is a rare autoinflammatory disorder characterized by recurrent episodes of inflammation. It is caused by mutations in the NLRP3 gene, which leads to overproduction of a protein called cryopyrin. This excessive production triggers the release of pro-inflammatory cytokines, resulting in systemic inflammation.
The symptoms of CAPS can vary in severity but commonly include recurrent fever, rash, joint pain, and fatigue. In severe cases, it can also affect organs such as the eyes, ears, and central nervous system. CAPS is typically diagnosed in childhood, but symptoms can persist into adulthood.
Treatment for CAPS aims to control inflammation and manage symptoms. This often involves the use of medications such as interleukin-1 inhibitors, which block the action of the pro-inflammatory cytokines. Early diagnosis and treatment are crucial in preventing long-term complications.
Cryopyrin-associated periodic syndrome is a rare autoinflammatory disorder characterized by recurrent episodes of inflammation caused by mutations in the NLRP3 gene. It presents with various symptoms and can affect multiple organs. Timely treatment is essential to manage the condition and prevent complications.